• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States.美国经导管主动脉瓣置换术中使用脑保护装置的早期经验。
JAMA Intern Med. 2020 May 1;180(5):783-784. doi: 10.1001/jamainternmed.2019.6767.
2
Cerebral embolic protection systems for transcatheter aortic valve replacement.用于经导管主动脉瓣置换术的脑栓塞保护系统。
J Interv Cardiol. 2018 Dec;31(6):891-898. doi: 10.1111/joic.12573. Epub 2018 Nov 22.
3
Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.经导管主动脉瓣置换术中使用前哨式脑保护系统的临床结局:系统评价和荟萃分析。
Cardiovasc Revasc Med. 2020 Jun;21(6):717-722. doi: 10.1016/j.carrev.2019.04.023. Epub 2019 Apr 25.
4
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.经导管主动脉瓣置换术中脑保护显著降低死亡率和卒率,优于无保护手术。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2297-2303. doi: 10.1016/j.jcin.2017.06.037. Epub 2017 Sep 13.
5
Ischaemic changes during transcatheter aortic valve implantation.经导管主动脉瓣植入术中的缺血性改变。
Heart. 2020 Jun;106(11):801-866. doi: 10.1136/heartjnl-2019-316020.
6
Filter neuroprotection of a single patent internal carotid artery during transapical aortic valve implantation.经心尖主动脉瓣植入术中单一专利颈内动脉的滤器神经保护作用。
J Card Surg. 2015 Mar;30(3):260-2. doi: 10.1111/jocs.12347. Epub 2014 Apr 22.
7
Cerebral protection devices during transcatheter aortic valve implantation.经导管主动脉瓣植入术中的脑保护装置
Trends Cardiovasc Med. 2018 Aug;28(6):412-418. doi: 10.1016/j.tcm.2018.01.007. Epub 2018 Feb 2.
8
Two-step approach to avoid obstruction of the coronary ostium during transcatheter aortic valve implantation with the SAPIEN 3.在使用SAPIEN 3进行经导管主动脉瓣植入术时避免冠状动脉口阻塞的两步法。
Cardiovasc Interv Ther. 2019 Jan;34(1):62-63. doi: 10.1007/s12928-017-0503-8. Epub 2017 Nov 25.
9
Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后的脑栓塞保护与卒中相关死亡率
JACC Cardiovasc Interv. 2022 Mar 14;15(5):569-571. doi: 10.1016/j.jcin.2022.01.007.
10
Judgment Reserved: The Evolving Development of Cerebral Embolic Protection Devices in Transcutaneous Aortic Valve Replacement.保留判决:经皮主动脉瓣置换术中脑栓塞保护装置的发展历程
J Cardiothorac Vasc Anesth. 2023 Feb;37(2):195-197. doi: 10.1053/j.jvca.2022.11.005. Epub 2022 Nov 8.

引用本文的文献

1
Evaluation of aortic arch calcification to predict prognosis after transcatheter aortic valve replacement.评估主动脉弓钙化以预测经导管主动脉瓣置换术后的预后。
Sci Rep. 2025 Feb 21;15(1):6396. doi: 10.1038/s41598-024-83536-8.
2
Temporal Improvement in Outcomes of Surgical Treatment of Isolated Tricuspid Regurgitation in the United States.美国单纯性三尖瓣反流手术治疗效果的时间性改善
JACC Adv. 2024 Oct 10;3(11):101319. doi: 10.1016/j.jacadv.2024.101319. eCollection 2024 Nov.
3
Cerebral Embolic Protection Devices: Current State of the Art.脑栓塞保护装置:当前技术水平
US Cardiol. 2023 Mar 31;17:e02. doi: 10.15420/usc.2022.12. eCollection 2023.
4
Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy.肥厚型梗阻性心肌病行间隔缩减治疗后的操作量与结局。
J Am Heart Assoc. 2024 Nov 5;13(21):e036387. doi: 10.1161/JAHA.124.036387. Epub 2024 Oct 25.
5
Outcomes and Predictors of Stroke After Transcatheter Aortic Valve Replacement in the Cerebral Protection Device Era.经脑保护装置时代经导管主动脉瓣置换术后的脑卒中结局和预测因素。
J Am Heart Assoc. 2024 Aug 6;13(15):e034298. doi: 10.1161/JAHA.124.034298. Epub 2024 Aug 5.
6
Patient Characteristics and Outcomes Associated with Sentinel Protection Device Use in Patients with Aortic Valve Disease Undergoing TAVR in a "Real-World" Setting.在“真实世界”环境中接受经导管主动脉瓣置换术(TAVR)的主动脉瓣疾病患者中,与使用哨兵保护装置相关的患者特征和结局
Rev Cardiovasc Med. 2024 Jan 4;25(1):3. doi: 10.31083/j.rcm2501003. eCollection 2024 Jan.
7
The Heart Brain Team and Patient-Centered Management of Ischemic Stroke.心脏-脑卒中介入团队与缺血性脑卒中的以患者为中心的管理
JACC Adv. 2022 Mar 16;1(1):100014. doi: 10.1016/j.jacadv.2022.100014. eCollection 2022 Mar.
8
Contemporary Trends in Same-Day Versus Deferred Discharge After Left Atrial Appendage Occlusion.左心耳封堵术后当日出院与延迟出院的当代趋势
JACC Adv. 2023 Mar 8;2(2):100261. doi: 10.1016/j.jacadv.2023.100261. eCollection 2023 Mar.
9
Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series.介入心脏病学中的时间年龄与生物年龄:为老年患者提供全面关怀的综合方法:JACC 家族系列。
JACC Cardiovasc Interv. 2024 Apr 22;17(8):961-978. doi: 10.1016/j.jcin.2024.01.284. Epub 2024 Apr 8.
10
Safety and efficacy of cerebral embolic protection in transcatheter aortic valve implantation: an updated meta-analysis.经导管主动脉瓣植入术中脑栓塞保护的安全性和有效性:一项更新的荟萃分析。
AsiaIntervention. 2024 Feb 29;10(1):51-59. doi: 10.4244/AIJ-D-23-00022. eCollection 2024 Feb.

本文引用的文献

1
Incidence, Predictors, and Outcomes of Acute Ischemic Stroke Following Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后急性缺血性脑卒中的发生率、预测因素和结局。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1497-1506. doi: 10.1016/j.jcin.2019.04.015.
2
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.经导管主动脉瓣置换术中使用脑保护装置时观察到的围手术期卒中发生率:一项基于患者倾向评分匹配的分析。
Eur Heart J. 2019 May 1;40(17):1334-1340. doi: 10.1093/eurheartj/ehy847.
3
Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.经导管主动脉瓣置换术后住院期间卒中风险预测模型的开发和应用:胸外科医生学会/美国心脏病学会经导管瓣膜治疗登记处报告。
Ann Thorac Surg. 2019 Apr;107(4):1097-1103. doi: 10.1016/j.athoracsur.2018.11.013. Epub 2018 Dec 7.
4
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.经导管主动脉瓣置换术中脑保护显著降低死亡率和卒率,优于无保护手术。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2297-2303. doi: 10.1016/j.jcin.2017.06.037. Epub 2017 Sep 13.
5
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术中的脑栓塞保护。
J Am Coll Cardiol. 2017 Jan 31;69(4):367-377. doi: 10.1016/j.jacc.2016.10.023. Epub 2016 Nov 1.

美国经导管主动脉瓣置换术中使用脑保护装置的早期经验。

Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States.

机构信息

Division of Cardiology, Department of Medicine, West Virginia University, Morgantown.

Department of Cardiology, Mayo Clinic School of Medicine, Rochester, Minnesota.

出版信息

JAMA Intern Med. 2020 May 1;180(5):783-784. doi: 10.1001/jamainternmed.2019.6767.

DOI:10.1001/jamainternmed.2019.6767
PMID:32091552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7042802/
Abstract

This survey study evaluates the early post–US Food and Drug Administration approval experience with an embolic protection device used during transcatheter aortic valve replacement procedures.

摘要

这项调查研究评估了经美国食品和药物管理局批准后,在经导管主动脉瓣置换术期间使用栓塞保护装置的早期经验。